What is Acceleration Laboratory Services?
Headquartered in Kansas City, Missouri, Acceleration Laboratory Services operates as a specialized contract research organization (CRO) serving the pharmaceutical, animal health, and nutraceutical industries. The firm distinguishes itself through a science-first methodology, providing comprehensive support across the entire development lifecycle. By integrating a solution-based approach with deep technical expertise, the company acts as an extension of its clients' internal teams, ensuring that complex research programs are executed with precision and regulatory compliance. Its strategic location facilitates rapid logistics and communication, enabling the firm to maintain a competitive edge in a global market that increasingly relies on outsourced, high-fidelity scientific support.
How much funding has Acceleration Laboratory Services raised?
Acceleration Laboratory Services has raised a total of $419K across 2 funding rounds:
Debt
$150K
Debt
$269K
Debt (2020): $150K with participation from PPP
Debt (2021): $269K led by PPP
Key Investors in Acceleration Laboratory Services
PPP
Public-Private Partnership
What's next for Acceleration Laboratory Services?
With the recent influx of capital, Acceleration Laboratory Services is well-positioned to accelerate its growth strategy, likely focusing on the expansion of its laboratory capacity and the integration of advanced analytical technologies. As the firm transitions through this late-stage funding cycle, the focus will shift toward enhancing its service portfolio to meet the evolving needs of the biopharmaceutical sector. Future initiatives are expected to prioritize operational efficiency and the scaling of its collaborative research model, ensuring that the company remains at the forefront of the drug development ecosystem while maintaining the high-touch, solution-oriented service that defines its market presence.
See full Acceleration Laboratory Services company page
